Efficacy and safety of tozorakimab in moderate-to-severe atopic dermatitis: A Phase 2a randomized controlled trial (FRONTIER-2) - Silverberg, JI; Mustapa, MN; Reid, F; Lei, A; Smith, R; Moate, R; Kelly, A; Chen, R; Gavala, M; Jimenez, E; Belvisi, MG; Sadiq, MW; et al. (JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2024)